Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins and ischemic stroke.

James K Liao1

  • 1Vascular Medicine Research, Brigham & Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA. jliao@rics.bwh.harvard.edu

Atherosclerosis. Supplements
|June 5, 2002
PubMed
Summary

Statins, or HMG-CoA reductase inhibitors, lower cholesterol and cardiovascular disease. Their benefits may extend beyond cholesterol reduction, potentially impacting vascular health and reducing ischemic stroke risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of adipocyte thermogenic program by Rho-associated coiled-coil containing kinase 2.

iScience·2026
Same author

Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo.

Journal of the American Heart Association·2026
Same author

Endothelial Rho kinase controls blood vessel integrity and angiogenesis.

Cardiovascular research·2025
Same author

Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.

The Lancet. Neurology·2025
Same author

ARNT-dependent HIF-2α signaling protects cardiac microvascular barrier integrity and heart function post-myocardial infarction.

Communications biology·2025
Same author

Endothelial Rho kinase controls blood vessel integrity and angiogenesis.

bioRxiv : the preprint server for biology·2024

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors (statins) are primary regulators of cholesterol synthesis.
  • Clinical trials confirm statins reduce cholesterol and cardiovascular disease incidence.
  • Emerging evidence suggests statins possess non-cholesterol-related vascular benefits.

Purpose of the Study:

  • To explore the pleiotropic effects of statins beyond cholesterol reduction.
  • To investigate the role of statins in vascular health, particularly concerning ischemic stroke.
  • To understand the impact of inhibiting isoprenoid intermediate synthesis.

Main Methods:

  • Review of large clinical trials and meta-analyses of statin efficacy.
  • Analysis of the biochemical pathway of cholesterol synthesis and statin's role.
  • Correlation analysis between serum cholesterol levels and ischemic stroke risk.

Main Results:

  • Statins effectively lower serum cholesterol and reduce cardiovascular disease.
  • Meta-analyses indicate statin benefits may exceed cholesterol-lowering effects.
  • Statins' inhibition of isoprenoid synthesis suggests vascular pleiotropic actions.
  • Reduced ischemic stroke incidence highlights statins' non-cholesterol effects.

Conclusions:

  • Statins exhibit pleiotropic effects on the vascular wall, independent of cholesterol reduction.
  • The non-cholesterol mechanisms of statins are crucial for reducing ischemic stroke.
  • Further research into statins' vascular effects is warranted.

Related Experiment Videos